A new treatment for prostate cancer developed and trialled in London has been licensed for use.
Enzalutamide was developed by researchers at the Royal Marsden and University College London hospitals.
The one a day pill checks the spread of the cancer.
Reseachers say the most exciting aspect of this new drug is that is has very few side effects- unlike many cancer treatements.
More top news
There's no better place than Vienna, apparently.
Abdul Quddus, 25, an imam at the Baitul Futuh mosque in Morden, visits colleges and universities to try combat messages of extremism.
"I think he was the best midfield player, all-round player I'd ever seen or played alongside...", Venables told ITV News.